IRadimed (IRMD)
Builds non-magnetic infusion, monitoring, and safety devices for MRI environments.
Something off on this page? Send us feedback.
Sells MRI-compatible infusion pumps, patient vital signs monitors, ferromagnetic detection systems, disposable tubing, and service plans. The business is a single-segment medical-device franchise with U.S.-heavy sales and product timing shaped by FDA clearance.
Designs and manufactures MRI-compatible medical devices for hospitals and acute-care facilities, centered on MRidium IV infusion pumps and the 3880 patient vital signs monitor. Related revenue comes from proprietary disposable tubing, extended maintenance, service, and the FMD1 ferromagnetic detection system for MRI-zone safety.
Sales are concentrated in the United States, where the company uses a direct field organization; international markets are served through independent distributors. The operating model is narrow: management reports a single MRI-compatible medical-device segment rather than separate product divisions.
Execution depends on non-magnetic device engineering, FDA clearance for regulated U.S. products, and a product upgrade cycle around the newer MRidium pump. The business also depends on a limited product set, specialized suppliers, a single Florida facility, and founder-led management.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 22, 2026 | Needham | Initiate | Rating: — | |
| Feb 11, 2026 | Lake Street | Target | Target: $100 | Target: $120 |
| Feb 10, 2026 | Roth Capital | Target | Target: $98 | Target: $120 |
| Nov 3, 2025 | Roth Capital | Target | Target: $90 | Target: $98 |
| Nov 3, 2025 | Lake Street | Target | Target: — | Target: $100 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $59.1M · Total debt $0 · Total assets $115.0M · Shareholders' equity $101.7M
- Revenue
- $20.5M
- Operating income
- $6.4M
- Net income
- $5.2M
HistoryDividendAnnual yield
| Institutions | 61.94% | 7.92M shares | |
|---|---|---|---|
| 218 holders · as of Jun 30, 2026 | |||
| Insiders | 34.98% | 4.47M shares | |
| 7 holders · as of Sep 8, 2026 | |||
| Other | 3.08% | 394.0K shares | |
| remainder | |||
12.79M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Roger E. Susi1Insiderdirector, 10 percent owner, officer: CEO, President, Chairman | 34.32% | 4.45M | filed Jun 2, 2026 |
BlackRock, Inc.Institution | 7.57% | 967,825 | as of Jun 30, 2026 |
Kayne Anderson Rudnick Investment Management LLCInstitution | 3.10% | 396,982 | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 3.08% | 394,412 | as of Jun 30, 2026 |
Copeland Capital Management, LLCInstitution | 3.06% | 391,860 | as of Jun 30, 2026 |
- Roger E. Susi's transaction reports restate only vehicles that traded; the 2026 ownership statement (4.45M) less the 62.5K net shares sold since is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 3, 2026 | Monty K. Allen | director | −1,419 | $86.41 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | director | −3,000 | $95.00 |
| Jun 1, 2026 | Roger E. Susi | director, 10 percent owner, officer: CEO, President, Chairman | −2,500 | $90.60 |
| May 27, 2026 | Roger E. Susi | director, 10 percent owner, officer: CEO, President, Chairman | −2,500 | $91.95 |
| May 26, 2026 | Roger E. Susi | director, 10 percent owner, officer: CEO, President, Chairman | −5,000 | $92.23 |
- Philips (ADR)
Dominant MRI patient-monitor rival through Invivo
- GE HealthCare
Large imaging vendor with MRI-monitoring overlap
- BD
Conventional infusion-system rival in MRI workarounds
- Baxter International
Connected infusion pumps for outside-room workarounds
- ICU Medical
Pure-play infusion company with Plum pump overlap
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| IRadimed | $86.72 | +0.24% | $1.11B | 48.3 | 37.1 | 12.8 | +0.3% |
| Philips (ADR) | $24.68 | −1.18% | $24.41B | 18.9 | 12.9 | 1.2 | −2.8% |
| GE HealthCare | $65.79 | −0.72% | $29.93B | 19.2 | 12.7 | 1.5 | +5.8% |
| BD | $182.98 | −0.01% | $50.42B | 55.1 | 13.8 | 2.4 | −9.6% |
| Baxter International | $23.67 | −0.04% | $12.24B | — | 11.2 | 1.1 | +5.3% |
| ICU Medical | $164.67 | +2.29% | $4.02B | 136.4 | 18.6 | 1.9 | −0.2% |
| Median | 37.2 | 12.9 | 1.5 | −0.2% |